Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Akebia Therapeutics Inc
NASDAQ:AKBA
Akebia Therapeutics Inc
NASDAQ:AKBA
Price:
0.7646
USD
15.78%
Market Closed
Market Cap:
$205.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Akebia Therapeutics Inc
NASDAQ:AKBA
|
US |
|
P
|
Pepkor Holdings Ltd
JSE:PPH
|
ZA |
|
G
|
GoGold Resources Inc
XMUN:GGD
|
CA |
|
S
|
Secom Co Ltd
DUS:XSC
|
JP |
|
Abl Group ASA
OSE:AQUA
|
NO |
|
R
|
Russel Metals Inc
OTC:RUSMF
|
CA |
|
B
|
Brookfield Business Holdings Corp
NYSE:BBUC
|
US |
|
S
|
Silvercorp Metals Inc
AMEX:SVM
|
CA |
|
Coles Group Ltd
ASX:COL
|
AU |
|
A
|
Alt Co Ltd (Gyeonggi-do)
KOSDAQ:459550
|
KR |
|
N
|
Neptune Co
KOSDAQ:217270
|
KR |
|
S
|
Somnigroup International Inc
SWB:TPD
|
US |
|
Renew Holdings PLC
F:LLP
|
UK |
|
D
|
Daesang Holdings Co Ltd
KRX:084695
|
KR |
|
Home REIT PLC
LSE:HOME
|
UK |
|
C
|
China Aerospace International Holdings Ltd
F:CIOC
|
HK |
|
L
|
Lagardere SA
XMUN:LAG
|
FR |
|
G
|
Goldex Resources Corp
F:G6T2
|
CA |
|
H
|
Huntington Bancshares Inc
XMUN:HU3
|
US |
|
P
|
Pepinnini Minerals Ltd
ASX:PNN
|
AU |
|
V
|
Vistance Networks Inc
XMUN:CM9
|
US |
|
G
|
Genflat Holdings Inc
OTC:GFLT
|
US |
|
S
|
Sixt SE
XMUN:SIX2
|
DE |
|
PLDT Inc
XPHS:TEL
|
PH |
Wall St Price Targets
AKBA Price Forecast
Based on 8 analysts
Based on 8 analysts
+434% Upside
from
$0.7646
today
Akebia Therapeutics Inc (AKBA)’s 12-month stock price forecast through October 2027 has a consensus target of $4.08, implying 434% upside. The forecast is based on price targets from 8 Wall Street analysts.
AKBA Analyst Rating
Based on 6 analysts
Based on 6 analysts
Analysts rate AKBA Strong buy, with 5 of 6 recommending Buy or Strong buy.
Akebia Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKBA's stock price target?
Price Target
4.08
USD
4.08
USD
According to Wall Street analysts, the average 1-year price target for AKBA is 4.08 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Akebia Therapeutics Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for Akebia Therapeutics Inc?
Projected CAGR
-9%
-9%
The compound annual growth rate for Gross Profit over the next 3 years is -9%.
What is the Operating Income forecast for Akebia Therapeutics Inc?
Projected CAGR
35%
35%
The compound annual growth rate for Operating Income over the next 8 years is 35%.